Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

281
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
281
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

2.1K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.1K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

317
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
317
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

735
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
735
Management of Insomnia01:19

Management of Insomnia

371
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
371
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

777
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
777

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Sodium Oxybate Mitigate the Symptoms of Schizophrenia?

Current neuropharmacology·2025
Same author

Depression and the Glutamate/GABA-Glutamine Cycle.

Current neuropharmacology·2024
Same author

The Alzheimer's Disease Brain, Its Microvasculature, and NADPH Oxidase.

Journal of Alzheimer's disease : JAD·2023
Same author

The Treatment of Parkinson's Disease with Sodium Oxybate.

Current molecular pharmacology·2022
Same author

Prevention of Lipotoxicity in Pancreatic Islets with Gammahydroxybutyrate.

Cells·2022
Same author

Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study.

Human psychopharmacology·2021

Related Experiment Video

Updated: Nov 9, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.7K

Sleep, Narcolepsy, and Sodium Oxybate.

Mortimer Mamelak1

  • 1Department of Psychiatry, Baycrest Hospital, University of Toronto, Toronto, Ontario, Canada.

Current Neuropharmacology
|April 8, 2021
PubMed
Summary

Sodium oxybate (SO) treats narcolepsy by acting as a GABAB agonist and antioxidant. It enhances brain energy, reduces oxidative stress, and balances neurotransmitters to improve sleep and alertness.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Sleep Medicine

Background:

  • Sodium oxybate (SO) is a long-standing treatment for narcolepsy with cataplexy.
  • Its therapeutic mechanisms involve GABAB receptor agonism, brain energy metabolism, and antioxidant properties.

Purpose of the Study:

  • To elucidate the multifaceted mechanisms of action of sodium oxybate in narcolepsy.
  • To explore its effects on brain energy, oxidative stress, and neurotransmitter balance.

Main Methods:

  • Review of existing pharmacological and physiological data on sodium oxybate.
  • Analysis of its metabolic pathways and receptor interactions.
  • Examination of its impact on neuronal activity and sleep architecture.

Main Results:

Keywords:
Sleepdepressionnarcolepsyoxidative stresssleep homeostasissodium oxybate

More Related Videos

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

12.2K
Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.6K

Related Experiment Videos

Last Updated: Nov 9, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.7K
Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

12.2K
Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.6K
  • SO acts as a weak GABAB agonist, influencing slow-wave and REM sleep.
  • Metabolism to succinate provides energy, while NADPH formation offers antioxidant effects.
  • SO improves alertness and may mitigate psychological stress by reducing ROS and correcting neurotransmitter imbalances.

Conclusions:

  • Sodium oxybate offers a unique therapeutic profile for narcolepsy through combined GABAB agonism, metabolic support, and antioxidant activity.
  • It effectively balances monoaminergic and cholinergic systems, addressing cataplexy and improving overall neurological function.
  • SO's potential to reduce oxidative stress and inflammation suggests broader applications beyond narcolepsy treatment.